var data={"title":"Vesiculopustular and bullous lesions in the newborn and infant","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Vesiculopustular and bullous lesions in the newborn and infant</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Josie A Pielop, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Leonard E Weisman, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 28, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vesicles, bullae, and pustules in the newborn may be caused by infections, congenital disorders, or other diseases. Benign and self-limited disorders, including erythema toxicum neonatorum (<a href=\"image.htm?imageKey=DERM%2F70785\" class=\"graphic graphic_picture graphicRef70785 \">picture 1A</a>), transient neonatal pustular melanosis (<a href=\"image.htm?imageKey=PEDS%2F59397%7EDERM%2F64567\" class=\"graphic graphic_picture graphicRef59397 graphicRef64567 \">picture 2A-B</a>), and neonatal acne (<a href=\"image.htm?imageKey=DERM%2F56615\" class=\"graphic graphic_picture graphicRef56615 \">picture 3</a>), do not require specific therapy. However, certain infections and genetic disorders must be differentiated from these self-limited conditions because treatment may be needed (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>).</p><p>Benign pustular eruptions, vesiculopustular eruptions caused by infections, and <span class=\"nowrap\">congenital/inherited</span> bullous diseases presenting in the newborn are reviewed here. Other benign neonatal skin and scalp lesions are discussed separately. (See <a href=\"topic.htm?path=benign-skin-and-scalp-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">&quot;Benign skin and scalp lesions in the newborn and infant&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3515631829\"><span class=\"h1\">BENIGN VESICULOPUSTULAR ERUPTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although most vesiculopustular eruptions in newborns are benign and self-limiting, the differential diagnosis includes conditions that require prompt recognition and treatment (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>). </p><p class=\"headingAnchor\" id=\"H3426440751\"><span class=\"h2\">Erythema toxicum neonatorum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythema toxicum neonatorum (ETN) is a common pustular disorder occurring in approximately 20 percent of neonates in the first 72 hours of life [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/1-3\" class=\"abstract_t\">1-3</a>]. It occurs more frequently in neonates with higher birthweight and greater gestational age. The etiology is unknown. One hypothesis is that ETN represents an acute, innate immune response to the penetration of skin-colonizing flora into the hair follicle [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/4\" class=\"abstract_t\">4</a>].</p><p>ETN presents with multiple erythematous macules and papules (1 to 3 mm in diameter) that rapidly progress to pustules on an erythematous base (<a href=\"image.htm?imageKey=DERM%2F70785%7EDERM%2F78577\" class=\"graphic graphic_picture graphicRef70785 graphicRef78577 \">picture 1A-B</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/5\" class=\"abstract_t\">5</a>]. The lesions are distributed over the trunk and proximal extremities, sparing the palms and soles. They may be present at birth but typically appear within 24 to 48 hours. The rash usually resolves in five to seven days, although it may wax and wane before complete resolution [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/6\" class=\"abstract_t\">6</a>].</p><p>The diagnosis of ETN is usually made based on the clinical appearance. It can be confirmed by microscopic examination of a Wright-stained smear of the contents of a pustule that demonstrates numerous eosinophils and occasional neutrophils. However, this usually is not necessary. A minority of patients (7 to 18 percent) may also have peripheral eosinophilia [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/7\" class=\"abstract_t\">7</a>]. If the presentation is atypical, cultures of the pustule contents for bacteria, fungi, and viruses should be obtained (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>); these are all negative in ETN. </p><p>ETN resolves spontaneously. No treatment is necessary.</p><p class=\"headingAnchor\" id=\"H1971323542\"><span class=\"h2\">Transient neonatal pustular melanosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transient neonatal pustular melanosis (TNPM) is less common than ETN. It mostly affects full-term black infants, although it is described in all ethnic groups [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/8\" class=\"abstract_t\">8</a>].</p><p>TNPM consists of three types of lesions [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/9\" class=\"abstract_t\">9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small pustules on a nonerythematous base; these usually are present at birth.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythematous to hyperpigmented macules with a surrounding collarette of scale (<a href=\"image.htm?imageKey=DERM%2F64567\" class=\"graphic graphic_picture graphicRef64567 \">picture 2B</a>); these develop as the pustules rupture and may persist for weeks to months.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperpigmented macules that gradually fade over several weeks to months (<a href=\"image.htm?imageKey=PEDS%2F59397\" class=\"graphic graphic_picture graphicRef59397 \">picture 2A</a>).</p><p/><p>Lesions in different stages may be present at the same time, even at birth [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/9\" class=\"abstract_t\">9</a>].</p><p>The diagnosis of TNPM is usually based upon the clinical appearance. Microscopic examination of a Wright-stained smear of the contents of a pustule demonstrates numerous neutrophils and, in contrast with ETN, rare eosinophils. However, this is usually not necessary. Culture, if performed, yields no organism. </p><p>No treatment is necessary.</p><p class=\"headingAnchor\" id=\"H480811413\"><span class=\"h2\">Eosinophilic pustular folliculitis of infancy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophilic pustular folliculitis of infancy (EPFI) is an uncommon dermatosis of unknown etiology occurring in newborns and infants. Its relationship with the adult eosinophilic pustular folliculitis (Ofuji disease) is uncertain. EPFI presents with recurrent crops of pruritic, follicular pustules, most commonly on the scalp (<a href=\"image.htm?imageKey=DERM%2F115760\" class=\"graphic graphic_picture graphicRef115760 \">picture 4</a>) but also on the extremities (<a href=\"image.htm?imageKey=DERM%2F115761\" class=\"graphic graphic_picture graphicRef115761 \">picture 5</a>). In a retrospective study of 61 cases of EPFI, the median age of onset was five months, with a male to female ratio of 4:1 [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/10\" class=\"abstract_t\">10</a>]. Tissue eosinophilia is a universal finding and can be demonstrated by smear or biopsy. Some infants also have blood eosinophilia. Recurrence is the rule, with outbreaks occurring at intervals of 1 to 12 weeks and resolving in one to four weeks. Complete resolution occurs by age three in most children [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/10\" class=\"abstract_t\">10</a>]. &#160;</p><p>The diagnosis is based upon clinical features, course, and the demonstration of eosinophils in pustule content or in skin biopsy. The differential diagnosis includes ETN, TNPM, infantile acropustulosis (IA), herpes simplex infection, and impetigo. </p><p>Treatment is symptomatic. Topical corticosteroids appear to be effective in hastening the lesions' resolution and controlling pruritus [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/10\" class=\"abstract_t\">10</a>]. </p><p class=\"headingAnchor\" id=\"H4121463882\"><span class=\"h2\">Neonatal cephalic pustulosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neonatal cephalic pustulosis is a common eruption that occurs in approximately 20 percent of infants and does not appear to run in families. Since this eruption is not caused by stimulation of sebaceous glands by maternal and endogenous androgens, the eruption is no longer referred to as &quot;neonatal acne&quot; in order to distinguish it from true infantile acne [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/11\" class=\"abstract_t\">11</a>] (see <a href=\"#H3098968329\" class=\"local\">'Infantile acne'</a> below). An inflammatory reaction to skin colonization with <em>Malassezia</em> species has been proposed as a pathogenetic mechanism, especially in severe cases, although one series found no correlation between disease severity and lesional <em>Malassezia</em> culture positivity or nonlesional skin colonization [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/12-14\" class=\"abstract_t\">12-14</a>]. &#160;</p><p>The mean age at onset is three weeks [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/15\" class=\"abstract_t\">15</a>]. The presence of inflammatory papules and pustules, the absence of comedones, and the characteristic distribution limited to the face (especially the cheeks) and sometimes the scalp, are diagnostic in most cases (<a href=\"image.htm?imageKey=DERM%2F115785\" class=\"graphic graphic_picture graphicRef115785 \">picture 6</a>). Neonatal cephalic pustulosis may appear very similar to miliaria rubra (<a href=\"image.htm?imageKey=DERM%2F115786%7EDERM%2F115787\" class=\"graphic graphic_picture graphicRef115786 graphicRef115787 \">picture 7A-B</a>). (See <a href=\"topic.htm?path=miliaria\" class=\"medical medical_review\">&quot;Miliaria&quot;</a>.)</p><p>In the majority of cases, neonatal cephalic pustulosis is mild and can be treated with daily cleansing with soap and water and avoidance of exogenous oils and lotions [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/16\" class=\"abstract_t\">16</a>]. The eruption usually resolves spontaneously within four months without scarring [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/16\" class=\"abstract_t\">16</a>]. Application of 2% <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> cream twice daily or 1% <a href=\"topic.htm?path=hydrocortisone-pediatric-drug-information\" class=\"drug drug_pediatric\">hydrocortisone</a> cream once daily may expedite clearance of lesions [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/17\" class=\"abstract_t\">17</a>]. Affected newborns do not appear to have a greater risk of acne in adolescence.</p><p class=\"headingAnchor\" id=\"H3098968329\"><span class=\"h2\">Infantile acne</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infantile acne is an uncommon and distinct entity from neonatal cephalic pustulosis. It typically presents at three to four months of age but may rarely occur in the first few weeks of life [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/18\" class=\"abstract_t\">18</a>]. It results from hyperplasia of sebaceous glands secondary to androgenic stimulation and is more common in boys [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19,20\" class=\"abstract_t\">19,20</a>]. The clinical presentation is more severe than that of cephalic pustulosis and consists of typical acneiform lesions, including comedones, inflammatory papules, pustules, and, sometimes, nodules on the face (<a href=\"image.htm?imageKey=DERM%2F115788%7EDERM%2F115789\" class=\"graphic graphic_picture graphicRef115788 graphicRef115789 \">picture 8A-B</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/11\" class=\"abstract_t\">11</a>]. It usually clears spontaneously by late in the first year of life but may persist until three years of age.</p><p>Treatment may be required because infantile acne can persist and occasionally cause scarring, unlike neonatal cephalic pustulosis. When inflammation is mild or moderate, mild keratolytic agents, such as <a href=\"topic.htm?path=benzoyl-peroxide-pediatric-drug-information\" class=\"drug drug_pediatric\">benzoyl peroxide</a> (2.5%), topical antibiotics (eg, <a href=\"topic.htm?path=erythromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">erythromycin</a>), or topical retinoids may be used [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/21\" class=\"abstract_t\">21</a>]. In more severe cases, systemic therapy with oral erythromycin or oral <a href=\"topic.htm?path=isotretinoin-pediatric-drug-information\" class=\"drug drug_pediatric\">isotretinoin</a> may be indicated [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/21,22\" class=\"abstract_t\">21,22</a>].</p><p>Parents should be instructed to test for local reaction to topical therapies by applying a small amount to the antecubital fossa before widespread use or application to the face [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/23\" class=\"abstract_t\">23</a>]. Topical therapies should initially be applied every other night and increased to every night as tolerated, unless otherwise indicated.</p><p>Severe, unremitting infantile acne may warrant evaluation for underlying androgen excess due to congenital adrenal hyperplasia, a gonadal or adrenal tumor, or precocious puberty [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/11,24\" class=\"abstract_t\">11,24</a>]. Some patients have recurrence of severe acne at puberty.</p><p class=\"headingAnchor\" id=\"H1556199306\"><span class=\"h2\">Miliaria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Miliaria is a common finding in newborns, especially in warm climates. It is caused by accumulation of sweat beneath eccrine sweat ducts that are obstructed by keratin at the level of the stratum corneum. (See <a href=\"topic.htm?path=miliaria\" class=\"medical medical_review\">&quot;Miliaria&quot;</a>.)</p><p>Several types of lesions may result [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19,23,25\" class=\"abstract_t\">19,23,25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria crystallina is characterized by small, thin-walled vesicles resembling dewdrops without inflammation (<a href=\"image.htm?imageKey=PEDS%2F55627\" class=\"graphic graphic_picture graphicRef55627 \">picture 9</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria rubra (&quot;heat rash,&quot; &quot;prickly heat&quot;) occurs when the obstructed sweat leaks into the dermis and causes a localized inflammatory response, resulting in small groups of erythematous papules and pustules (<a href=\"image.htm?imageKey=PEDS%2F68376\" class=\"graphic graphic_picture graphicRef68376 \">picture 10</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria pustulosa also results from localized inflammation; it consists of pustules with an erythematous base similar to miliaria rubra.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Miliaria profunda is papular or papulopustular and skin colored.</p><p/><p>Miliaria rarely is present at birth. It usually develops during the first week of life, especially in association with warming of the infant by an incubator, occlusive dressings or clothing, or fever. It is characteristically distributed on the face, scalp, and intertriginous areas.</p><p>The diagnosis of miliaria is based upon the clinical features. Microscopic examination of a Wright-stained smear of the contents of a vesicular lesion demonstrates sparse squamous cells and lymphocytes. However, this is usually not necessary.</p><p>No specific treatment is needed. Lesions usually resolve rapidly when the infant is placed in a cooler environment with associated measures to reduce sweating, such as light, loose clothing, and cool baths. </p><p class=\"headingAnchor\" id=\"H416223681\"><span class=\"h2\">Infantile acropustulosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infantile acropustulosis (IA) is a benign vesiculopustular condition with an often more chronic course than other benign neonatal lesions. The etiology is unknown. A nonspecific hypersensitivity reaction to scabies has been postulated because many patients have been treated for scabies before being diagnosed with IA [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/26,27\" class=\"abstract_t\">26,27</a>]. However, the diagnosis of scabies in these patients was rarely verified microscopically [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"abstract_t\">27</a>]. One survey suggested that IA is common in internationally adopted children, many of whom had been diagnosed with scabies after living in crowded living conditions early in life [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/28\" class=\"abstract_t\">28</a>].</p><p>Some suggest that black male infants are more commonly affected [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/29\" class=\"abstract_t\">29</a>], but others found no gender or racial predisposition [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/30\" class=\"abstract_t\">30</a>]. A family history may be informative because siblings are sometimes affected [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/30\" class=\"abstract_t\">30</a>].</p><p>IA is characterized by recurrent crops of intensely pruritic vesiculopustules, mainly on the palms and soles (<a href=\"image.htm?imageKey=DERM%2F115791%7EDERM%2F77411\" class=\"graphic graphic_picture graphicRef115791 graphicRef77411 \">picture 11A-B</a>) but sometimes involving the dorsal aspect of the hands and feet and the limbs (<a href=\"image.htm?imageKey=DERM%2F55499%7EDERM%2F115792\" class=\"graphic graphic_picture graphicRef55499 graphicRef115792 \">picture 12A-B</a>). It may be present at birth or have onset any time during the first year of life. Recurrences generally occur every two to four weeks and may last 5 to 10 days. Infants are often fussy during these flares.</p><p>The differential diagnosis of IA includes dyshidrotic eczema, pustular psoriasis, ETN, TNPM, EPFI, scabies, and impetigo (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/5\" class=\"abstract_t\">5</a>]. (See <a href=\"topic.htm?path=acute-palmoplantar-eczema-dyshidrotic-eczema\" class=\"medical medical_review\">&quot;Acute palmoplantar eczema (dyshidrotic eczema)&quot;</a> and <a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a> and <a href=\"#H3426440751\" class=\"local\">'Erythema toxicum neonatorum'</a> above and <a href=\"#H1971323542\" class=\"local\">'Transient neonatal pustular melanosis'</a> above.)</p><p>The diagnosis of IA is based upon clinical features. Because of the association with scabies, skin scrapings should be examined [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27,31\" class=\"abstract_t\">27,31</a>]. Skin biopsy usually is not necessary but, if performed, demonstrates a subcorneal pustule filled with neutrophils and eosinophils [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/32\" class=\"abstract_t\">32</a>].</p><p>IA typically resolves within two years. Therapy for IA has not been studied in randomized trials, and the optimal treatment is controversial. Treatment with topical corticosteroids, oral antihistamines, oral <a href=\"topic.htm?path=erythromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">erythromycin</a>, and oral <a href=\"topic.htm?path=dapsone-pediatric-drug-information\" class=\"drug drug_pediatric\">dapsone</a> have been beneficial in case reports or case series, although the findings are inconsistent except for dapsone [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27,30,32-35\" class=\"abstract_t\">27,30,32-35</a>]. Although dapsone is reliably effective, it has potentially serious adverse effects [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"abstract_t\">27</a>].</p><p>In the largest series of IA patients, 20 of 21 were treated with high- to mid-potency topical corticosteroids (group 1 to 4 (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 2</a>)) once or twice per day [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"abstract_t\">27</a>]. The 18 who returned for follow-up had improvement (decrease in the number of lesions, frequency of recurrence, and pruritus) or marked improvement (complete resolution with no recurrence). Improvement was noted between three days and two weeks after initiation of therapy. No cutaneous or systemic complications were recorded.</p><p>We suggest mid- to high-potency topical corticosteroids (group 1 to 4 (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 2</a>)) as the first-line treatment for flares of IA [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27,30\" class=\"abstract_t\">27,30</a>]. Systemic absorption of topical corticosteroids in IA is limited by the localized distribution of the lesions, the thickness of skin in the affected (acral) areas, and the periodicity of the flares [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/5,27\" class=\"abstract_t\">5,27</a>]. (See <a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use#H14\" class=\"medical medical_review\">&quot;General principles of dermatologic therapy and topical corticosteroid use&quot;, section on 'Use in children'</a>.)</p><p><a href=\"topic.htm?path=erythromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">Erythromycin</a> (40 <span class=\"nowrap\">mg/kg</span> per day by mouth) or oral antihistamines are alternatives to topical corticosteroids. Erythromycin appears to have an anti-inflammatory effect. Antihistamines are effective in relieving pruritus but only in high doses, suggesting that sedation is necessary for efficacy [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27,34\" class=\"abstract_t\">27,34</a>].</p><p>We suggest that <a href=\"topic.htm?path=dapsone-pediatric-drug-information\" class=\"drug drug_pediatric\">dapsone</a> (1 to 2 <span class=\"nowrap\">mg/kg</span> per day by mouth) be reserved for severe, recalcitrant cases [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"abstract_t\">27</a>]. Adverse effects of dapsone may include peripheral neuropathy, aplastic anemia, hepatitis, hemolytic anemia, and methemoglobinemia [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"abstract_t\">27</a>]. A glucose-6-phosphate dehydrogenase (G6PD) screen should be done before starting dapsone. (See <a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">&quot;Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H799739628\"><span class=\"h2\">Vesiculopustular eruption and transient myeloproliferative disorder in Down syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 20 percent of newborns with Down syndrome present with a transient myeloproliferative disorder (TMD, also called transient leukemia) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/36-38\" class=\"abstract_t\">36-38</a>]. In rare instances, TMD is accompanied by a vesiculopustular eruption predominantly located on the face that begins during the first few days of life. The examination of a skin biopsy shows intraepidermal, spongiotic vesiculopustules and a perivascular infiltrate containing immature myeloid cells, which are usually also present in the peripheral blood. The skin lesions resolve spontaneously in one to three months, as the TMD regresses. (See <a href=\"topic.htm?path=down-syndrome-clinical-features-and-diagnosis#H15\" class=\"medical medical_review\">&quot;Down syndrome: Clinical features and diagnosis&quot;, section on 'Transient myeloproliferative disorder'</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">INFECTIOUS VESICULOPUSTULAR ERUPTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection always should be considered as a cause of vesiculobullous or pustular lesions in the newborn. Infectious disorders may be life threatening and require urgent therapeutic intervention. The clinical features of the most common infectious vesiculopustular eruptions in newborns are summarized in the table (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Viral infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of viruses can cause vesiculopustular or bullous lesions in the newborn. In most cases, lesions do not appear at birth but rather days to weeks later. Herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most common, but cytomegalovirus (CMV) and coxsackieviruses occasionally can induce these types of skin lesions. In the past, variola virus (smallpox) was also in the differential diagnosis. (See <a href=\"topic.htm?path=overview-of-cytomegalovirus-infections-in-children\" class=\"medical medical_review\">&quot;Overview of cytomegalovirus infections in children&quot;</a> and <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Primary herpes simplex infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neonatal HSV infection primarily results from intrapartum exposure to maternal cervical or vaginal lesions or by an ascending infection, sometimes through apparently intact membranes [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/39\" class=\"abstract_t\">39</a>]. Postnatal inoculation also may occur. </p><p>Symptoms can develop within days to four weeks after birth. HSV infection in newborns usually develops in one of three patterns:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Localized to the skin, eyes, and mouth</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Localized central nervous system (CNS) disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fulminant, disseminated disease involving multiple organs</p><p/><p>Skin lesions occur in the majority of patients and may be present in all three patterns. The skin lesions typically consist of 1 to 3 mm vesicles and erythematous papules that may develop into pustules, crusts, and erosions (<a href=\"image.htm?imageKey=PEDS%2F75059\" class=\"graphic graphic_picture graphicRef75059 \">picture 13</a>). They usually occur on the scalp (<a href=\"image.htm?imageKey=DERM%2F115776\" class=\"graphic graphic_picture graphicRef115776 \">picture 14</a>), sometimes associated with placement of a fetal monitor electrode, or face (<a href=\"image.htm?imageKey=DERM%2F115777\" class=\"graphic graphic_picture graphicRef115777 \">picture 15</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Lesions also may occur on the trunk (<a href=\"image.htm?imageKey=DERM%2F115778\" class=\"graphic graphic_picture graphicRef115778 \">picture 16</a>) or buttocks (especially with a breech presentation).</p><p>Lesions are not usually present at birth and develop at 6 to 13 days of age [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Infants with lesions at birth (congenital HSV infection) have intrauterine, rather than perinatal, infection and usually also are premature. They also can be microcephalic. Lesions should be distinguished from other vesiculopustular disorders (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>), such as congenital candidiasis, transient pustular melanosis of the newborn (<a href=\"image.htm?imageKey=PEDS%2F59397%7EDERM%2F64567\" class=\"graphic graphic_picture graphicRef59397 graphicRef64567 \">picture 2A-B</a>), or incontinentia pigmenti (<a href=\"image.htm?imageKey=DERM%2F58769\" class=\"graphic graphic_picture graphicRef58769 \">picture 17</a>). When lesions are present at birth, they usually appear as superficial erosions.</p><p>Although most lesions in older children are self-limited, neonatal infections are more likely to disseminate. Newborns with disseminated disease often appear septic, with vascular instability, hepatic dysfunction, disseminated intravascular coagulation, <span class=\"nowrap\">and/or</span> respiratory failure. CNS disease presents with fever, lethargy, and focal seizures.</p><p>The clinical manifestations, diagnosis, treatment, and prognosis of neonatal HSV infection are discussed in detail separately. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H4\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Varicella-zoster</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Perinatally acquired varicella is a rare and serious illness associated with a mortality rate up to 20 percent [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/40\" class=\"abstract_t\">40</a>]. Newborns born to mothers who are exposed to VZV or have clinical disease manifestations within three weeks of delivery are at the greatest risk for infection. If the mother develops the rash between four days before and two days after delivery, the newborn is likely to develop a generalized and potentially fatal infection (<a href=\"image.htm?imageKey=DERM%2F115779\" class=\"graphic graphic_picture graphicRef115779 \">picture 18</a>). Varicella-zoster infection in the newborn is discussed in detail separately. (See <a href=\"topic.htm?path=varicella-zoster-infection-in-the-newborn\" class=\"medical medical_review\">&quot;Varicella-zoster infection in the newborn&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Bacterial infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial infection in neonates may present with vesiculobullous or pustular lesions. The most common organism to cause pustules accompanying neonatal sepsis is <em>Staphylococcus aureus</em>. Because up to 60 percent of infants become colonized in the first few weeks of life, this organism is also an important cause of superficial skin infections [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/41\" class=\"abstract_t\">41</a>]. Sepsis caused by <em>Listeria monocytogenes</em>, streptococcal species, or <em>Pseudomonas aeruginosa </em>can have associated skin lesions, as can <em>Treponema pallidum</em> infection (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Staphylococcal pustulosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In newborns, cutaneous staphylococcal infection usually presents with superficial vesicular, pustular, or bullous lesions on an erythematous base. Vesicles and bullae are easily ruptured, resulting in superficial erosions and honey-colored crusts. Lesions usually are found in areas of trauma, such as the diaper area (<a href=\"image.htm?imageKey=PEDS%2F107272\" class=\"graphic graphic_picture graphicRef107272 \">picture 19</a>), circumcision wound, axillae, and periumbilical skin, although they may appear anywhere on the body.</p><p>The diagnosis is confirmed with demonstration of gram-positive cocci in clusters, neutrophils on a Gram stain of the pustular fluid, and isolation of <em>S. aureus</em> on culture. If lesions are extensive or the infant appears ill, a blood culture should be obtained prior to starting treatment.</p><p>The evaluation and treatment (<a href=\"image.htm?imageKey=PEDS%2F113285\" class=\"graphic graphic_algorithm graphicRef113285 \">algorithm 1</a>) of <em>S. aureus</em> skin infection in the newborn infant are discussed separately. (See <a href=\"topic.htm?path=suspected-staphylococcus-aureus-and-streptococcal-skin-and-soft-tissue-infections-in-neonates-evaluation-and-management#H2164651994\" class=\"medical medical_review\">&quot;Suspected Staphylococcus aureus and streptococcal skin and soft tissue infections in neonates: Evaluation and management&quot;, section on 'Antimicrobial therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Staphylococcal scalded skin syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Newborns are especially susceptible to dissemination of <em>S. aureus</em> exfoliative toxins, producing the staphylococcal scalded skin syndrome (SSSS or Ritter disease) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/42\" class=\"abstract_t\">42</a>]. The toxins act at the zona granulosa of the epidermis, causing cleavage of desmoglein 1 complex, an important protein in desmosomes (the organelles that help anchor keratinocytes to each other) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/43\" class=\"abstract_t\">43</a>]. This results in the formation of fragile, flaccid bullae that often are no longer intact by the time of presentation [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/44\" class=\"abstract_t\">44</a>].</p><p>Presentation usually occurs at three to seven days of age and is rarely seen at birth [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Affected infants are febrile and irritable, with diffuse, blanching erythema often beginning around the mouth. Flaccid blisters appear one to two days later, especially in areas of mechanical stress, including flexural areas, buttocks, hands, and feet (<a href=\"image.htm?imageKey=DERM%2F50249%7EDERM%2F72261\" class=\"graphic graphic_picture graphicRef50249 graphicRef72261 \">picture 20A-B</a>). Gentle pressure applied to the skin results in separation of the upper epidermis and wrinkling of the skin (Nikolsky's sign). In some cases, the entire upper epidermis may be shed [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Affected infants often have conjunctivitis; mucous membranes are not involved but may appear hyperemic.</p><p>Flaky desquamation occurs as the lesions heal [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/19\" class=\"abstract_t\">19</a>]. Because the cleavage plane of the blisters is intraepidermal, scars do not occur.</p><p>If SSSS is suspected, cultures should be obtained from blood, urine, nasopharynx, umbilicus, abnormal skin, or any suspected focus of infection. The intact bullae are sterile. Diagnosis is usually clinical, although it may be confirmed with skin biopsy that shows a cleavage plane in the lower stratum granulosum with minimal necrosis [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/45\" class=\"abstract_t\">45</a>]. However, biopsy is rarely required. The microscopic examination may be performed on a frozen section to expedite treatment.</p><p>The biopsy will differentiate SSSS from toxic epidermal necrolysis (TEN), which is more commonly seen in older children as a reaction to drugs or infections [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/46\" class=\"abstract_t\">46</a>]. Pathology specimens of TEN reveal a subepidermal cleavage plane and epidermal necrosis. Additionally, unlike SSSS, involvement of mucous membranes is a frequent clinical feature of TEN. (See <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p>Treatment consists of prompt administration of intravenous penicillinase-resistant penicillin, such as <a href=\"topic.htm?path=nafcillin-pediatric-drug-information\" class=\"drug drug_pediatric\">nafcillin</a> or <a href=\"topic.htm?path=oxacillin-pediatric-drug-information\" class=\"drug drug_pediatric\">oxacillin</a>; treatment with <a href=\"topic.htm?path=vancomycin-pediatric-drug-information\" class=\"drug drug_pediatric\">vancomycin</a> should be considered in areas with a high prevalence of community-acquired methicillin-resistant <em>S. aureus</em> (CA-MRSA) or for patients who fail to respond to initial therapy, as SSSS secondary to MRSA infection has been reported (<a href=\"image.htm?imageKey=PEDS%2F64140\" class=\"graphic graphic_table graphicRef64140 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/47,48\" class=\"abstract_t\">47,48</a>]. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-in-children-treatment-of-invasive-infections#H24\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus in children: Treatment of invasive infections&quot;, section on 'Treatment of neonates'</a>.)</p><p>Supportive skin care should be provided with the use of emollients, such as creams or ointments, to improve barrier function. Fluid and electrolyte status should be monitored with losses replaced as needed.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Streptococcal infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Streptococcal skin infections may mimic those caused by staphylococci, although they are less common. Epidemics of group A <em>Streptococcus</em> (GAS) infections have been reported [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/49,50\" class=\"abstract_t\">49,50</a>]. Affected newborns may present with pustules and honey-colored crusts, often in association with a moist umbilical cord stump or omphalitis.</p><p>Group B streptococci (GBS) most commonly cause neonatal sepsis. However, skin lesions, such as bullae, erosions, and honey-colored crusts, occur rarely. Unlike other bacterial skin lesions, those resulting from GBS may be present at birth or develop later [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/51\" class=\"abstract_t\">51</a>]. (See <a href=\"topic.htm?path=group-b-streptococcal-infection-in-neonates-and-young-infants#H11\" class=\"medical medical_review\">&quot;Group B streptococcal infection in neonates and young infants&quot;, section on 'Clinical manifestations'</a>.)</p><p>If streptococcal disease is suspected, Gram stain and culture of a skin lesion should be obtained. Gram-positive cocci in chains will distinguish these from staphylococcal infections, although culture is necessary to distinguish GAS from GBS. Cultures of blood, urine, and cerebrospinal fluid are obtained to rule out evidence of disseminated disease. </p><p>Pending the culture results, empiric therapy with intravenous <a href=\"topic.htm?path=ampicillin-pediatric-drug-information\" class=\"drug drug_pediatric\">ampicillin</a> and <a href=\"topic.htm?path=gentamicin-pediatric-drug-information\" class=\"drug drug_pediatric\">gentamicin</a> should be administered. Once GBS is identified as the sole causative organism, the therapy can be changed to <a href=\"topic.htm?path=penicillin-g-intravenous-and-short-acting-intramuscular-pediatric-drug-information\" class=\"drug drug_pediatric\">penicillin G</a> alone (<a href=\"image.htm?imageKey=ID%2F66906\" class=\"graphic graphic_table graphicRef66906 \">table 4</a>). (See <a href=\"topic.htm?path=group-b-streptococcal-infection-in-neonates-and-young-infants#H27\" class=\"medical medical_review\">&quot;Group B streptococcal infection in neonates and young infants&quot;, section on 'Antimicrobial therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Listeriosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infections resulting from <em>L. monocytogenes</em> can present in newborns [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/52\" class=\"abstract_t\">52</a>]. Clinical manifestations can occur early, before seven days, or late (after seven days). Both forms can present with meningitis and signs of septicemia. Infants with the early form often have multiple pustules on the skin and mucous membranes. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-listeria-monocytogenes-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Listeria monocytogenes infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Congenital syphilis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital syphilis occurs when the spirochete <em>T. pallidum</em> is transmitted from a pregnant woman to her fetus. It should always be included in the differential diagnosis of a newborn with blisters or erosions, especially when present at birth. (See <a href=\"topic.htm?path=congenital-syphilis-clinical-features-and-diagnosis#H28809272\" class=\"medical medical_review\">&quot;Congenital syphilis: Clinical features and diagnosis&quot;, section on 'Early congenital syphilis'</a>.)</p><p>Early manifestations can be quite variable. Infants may be normal at birth and become symptomatic during the first five weeks of life. Hemorrhagic bullae and petechiae that start on the palms and soles and spread to the trunk and extremities are nearly pathognomonic of congenital syphilis (<a href=\"image.htm?imageKey=DERM%2F115793%7EPEDS%2F81352\" class=\"graphic graphic_picture graphicRef115793 graphicRef81352 \">picture 21A-B</a>). If ulcerative in nature, they are highly contagious. A more common presentation is a papulosquamous eruption similar to the exanthem of secondary syphilis in adults (<a href=\"image.htm?imageKey=DERM%2F115794\" class=\"graphic graphic_picture graphicRef115794 \">picture 22</a>) or a desquamative dermatitis also involving the palms and soles. Other early manifestations include rhinitis (snuffles), anemia, thrombocytopenia, lymphadenopathy, hepatomegaly, fever, and poor feeding [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/53\" class=\"abstract_t\">53</a>].</p><p>The diagnosis and treatment of congenital syphilis are discussed separately. (See <a href=\"topic.htm?path=congenital-syphilis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Congenital syphilis: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=congenital-syphilis-evaluation-management-and-prevention#H21000446\" class=\"medical medical_review\">&quot;Congenital syphilis: Evaluation, management, and prevention&quot;, section on 'Evaluation and management of infants &lt;1 month of age'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Fungal infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Candida albicans</em> infections are common in the neonatal period and are usually benign. Case reports have been published of <em>Aspergillus</em> species causing vesicular lesions in very low birth weight newborns [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/54,55\" class=\"abstract_t\">54,55</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Neonatal candidiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neonatal candidiasis usually develops after the first week of life. It is most likely to affect moist, warm regions and skin folds, such as in the diaper area, or mucous membranes in the mouth, where it is known as thrush. Candidal diaper dermatitis characteristically appears as an erythematous rash in the inguinal region. The rash classically has areas of confluent erythema with multiple tiny pustules or discrete, erythematous papules and plaques with superficial scales (<a href=\"image.htm?imageKey=DERM%2F115796\" class=\"graphic graphic_picture graphicRef115796 \">picture 23</a>). Satellite lesions are typically noted (<a href=\"image.htm?imageKey=DERM%2F115797%7EPEDS%2F59361\" class=\"graphic graphic_picture graphicRef115797 graphicRef59361 \">picture 24A-B</a>). Topical treatment is adequate in most cases, as dissemination is rare. (See <a href=\"topic.htm?path=diaper-dermatitis\" class=\"medical medical_review\">&quot;Diaper dermatitis&quot;</a>.)</p><p>Oropharyngeal candidiasis or thrush can manifest in several ways. The pseudomembranous form is the most common and appears as white plaques on the buccal mucosa, palate, tongue, or the oropharynx. Infants with thrush may be totally asymptomatic or may refuse to eat because of discomfort from the infection. Topical therapy (eg, <a href=\"topic.htm?path=nystatin-pediatric-drug-information\" class=\"drug drug_pediatric\">nystatin</a>) is usually effective. In breastfeeding infants, the mother also may require treatment. (See <a href=\"topic.htm?path=candida-infections-in-children#H3\" class=\"medical medical_review\">&quot;Candida infections in children&quot;, section on 'Oropharyngeal candidiasis'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Congenital candidiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital cutaneous candidiasis is a rare disorder that results from a <em>Candida</em> spp. infection acquired in utero or during delivery. It presents at birth or in the first few days of life with small, diffuse, erythematous macules and pustules, often involving the palms and soles (<a href=\"image.htm?imageKey=PEDS%2F68825%7EDERM%2F94975\" class=\"graphic graphic_picture graphicRef68825 graphicRef94975 \">picture 25A-B</a>). The clinical manifestations and treatment of congenital candidiasis are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candida-infection-in-neonates#H7\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Candida infection in neonates&quot;, section on 'Congenital candidiasis'</a> and <a href=\"topic.htm?path=treatment-of-candida-infection-in-neonates\" class=\"medical medical_review\">&quot;Treatment of Candida infection in neonates&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2649463040\"><span class=\"h2\">Infestations</span></p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Scabies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Scabies is an uncommon cause of eruptions in the developed world but is common worldwide [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/56\" class=\"abstract_t\">56</a>]. The disorder is caused by infestation with the <em>Sarcoptes scabiei</em> mite. The skin eruption is because of a hypersensitivity reaction to the proteins of the female parasite, which burrows into the upper layers of the epidermis [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/57\" class=\"abstract_t\">57</a>]. Transmission of scabies is usually from person to person by direct contact. (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p>Scabies may present as early as three to four weeks of age, the earliest time infants can develop hypersensitivity to the mites, and is never present at birth. The characteristic appearance is of erythematous papules that are intensely pruritic. Infants are more likely than older children to develop vesicles, pustules, and crusting [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/58\" class=\"abstract_t\">58</a>]. The involvement usually is widespread and often affects the hands, feet, and wrists, which usually are spared in older children and adults (<a href=\"image.htm?imageKey=DERM%2F115804\" class=\"graphic graphic_picture graphicRef115804 \">picture 26</a>). The face may be involved because of contact with infested maternal skin while breastfeeding. Infants may manifest poor feeding, fussiness, and failure to thrive, presumably because of the intense pruritus, or be asymptomatic [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/59\" class=\"abstract_t\">59</a>].</p><p>The diagnosis should be considered in an infant with a vesiculopustular eruption that involves the palms and soles (<a href=\"image.htm?imageKey=DERM%2F76789\" class=\"graphic graphic_picture graphicRef76789 \">picture 27</a>). It is often confused with infantile acropustulosis, insect bites, impetigo, or urticaria pigmentosa. The combination of a pruritic eruption, characteristic distribution, and family involvement is usually enough to establish a diagnosis. Mites or eggs can be demonstrated in scrapings from burrows or papules. </p><p>The infant and all the household and close contacts should be treated simultaneously, and environmental decontamination should also be performed. Treatment consists of one application of <a href=\"topic.htm?path=permethrin-pediatric-drug-information\" class=\"drug drug_pediatric\">permethrin</a> 5% cream at bedtime to all skin surfaces in infants and from the neck down in older family members; it should be washed off after 8 to 14 hours [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/56\" class=\"abstract_t\">56</a>]. Repeated applications may be needed, as the failure rate is significant. Ten to 20 percent of patients require retreatment in 7 to 10 days because of persistent symptoms [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/60\" class=\"abstract_t\">60</a>]. An alternative therapy for newborns is the application of 5 to 10% precipitated sulfur in petrolatum.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">CONGENITAL/INHERITED BULLOUS DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several uncommon congenital or inherited conditions may present with bullous lesions in the newborn.</p><p class=\"headingAnchor\" id=\"H1065231708\"><span class=\"h2\">Sucking blisters</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital sucking blisters, a diagnosis of exclusion, are noninflammatory, oval, thick-walled vesicles or bullae that contain sterile fluid [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/61\" class=\"abstract_t\">61</a>]. The lesions may be unilateral or bilateral and typically are located on the dorsal or radial aspect of the wrists, hands, or fingers of neonates who are noted to suck excessively at the involved regions (<a href=\"image.htm?imageKey=PEDS%2F78479\" class=\"graphic graphic_picture graphicRef78479 \">picture 28</a>).</p><p>The differential diagnosis of sucking blisters includes herpes simplex virus infection, bullous impetigo, congenital syphilis or candidiasis, neonatal lupus erythematosus, and hereditary bullous diseases [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/61\" class=\"abstract_t\">61</a>]. These disorders are usually, but not always, accompanied by additional clinical signs or suggestive maternal history. </p><p>Observation of the neonate's sucking on the involved areas is the most helpful clue to the correct diagnosis of congenital sucking blisters. Other suggestive features include the absence of lesions in other areas, well appearance of the infant, and rapid resolution of the lesions.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Epidermolysis bullosa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidermolysis bullosa (EB) is a group of inherited diseases characterized by skin fragility and blister formation caused by minor skin trauma (<a href=\"image.htm?imageKey=DERM%2F86267\" class=\"graphic graphic_picture graphicRef86267 \">picture 29</a>). EB is broadly classified into four groups, based upon the level at which the blisters form. These are EB simplex, junctional EB, dystrophic EB (DEB), and Kindler syndrome. The pathogenesis, clinical manifestations, diagnosis, and management of EB and Kindler syndrome are discussed in detail separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Diagnosis of epidermolysis bullosa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">&quot;Overview of the management of epidermolysis bullosa&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=kindler-syndrome\" class=\"medical medical_review\">&quot;Kindler syndrome&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1181776286\"><span class=\"h2\">Bullous dermolysis of the newborn</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bullous dermolysis of the newborn (BDN), previously called transient bullous dermolysis of the newborn, is a subtype of DEB characterized by skin fragility and blister formation at birth that typically improves or resolves within the first year of life (<a href=\"image.htm?imageKey=DERM%2F115799\" class=\"graphic graphic_picture graphicRef115799 \">picture 30</a>) [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/62,63\" class=\"abstract_t\">62,63</a>]. Ultrastructurally, BDN shares the characteristic findings of DEB, namely a split below the level of the lamina densa, disruption of anchoring fibrils, and presence of electron-dense stellate or rod-like bodies within the dilated, rough, endoplasmic reticulum of basal keratinocytes.</p><p>On immunofluorescence microscopy, intracytoplasmic, epidermal inclusions of C7 appear to be a unique characteristic of BDN [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/62\" class=\"abstract_t\">62</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Epidermolytic ichthyosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidermolytic ichthyosis, also called epidermolytic hyperkeratosis (EHK) or bullous congenital ichthyosiform erythroderma, is an autosomal dominant disorder that typically presents in the neonatal period. Raw erosions are present at birth and may be misdiagnosed as EB (<a href=\"image.htm?imageKey=DERM%2F90570\" class=\"graphic graphic_picture graphicRef90570 \">picture 31</a>). Bullae, although not intact at birth, may continue to form throughout early childhood. (See <a href=\"topic.htm?path=keratinopathic-ichthyoses\" class=\"medical medical_review\">&quot;Keratinopathic ichthyoses&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Aplasia cutis congenita</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Aplasia cutis congenita (ACC) is a rare, heterogeneous group of congenital disorders characterized by focal or widespread absence of the skin [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/64\" class=\"abstract_t\">64</a>]. ACC can occur anywhere on the body, but the vast majority of cases occur on the scalp midline as a solitary membranous or bullous lesion (<a href=\"image.htm?imageKey=DERM%2F89935\" class=\"graphic graphic_picture graphicRef89935 \">picture 32</a>). A conspicuous collar of hair around a lesion on the scalp may indicate the presence of an underlying neurologic defect (<a href=\"image.htm?imageKey=DERM%2F114481\" class=\"graphic graphic_picture graphicRef114481 \">picture 33</a>). Clinical subtypes are characterized by their location and pattern of lesions, associated malformations, and mode of inheritance [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/65\" class=\"abstract_t\">65</a>].</p><p>The classification, diagnosis, and management of ACC are discussed in detail elsewhere. (See <a href=\"topic.htm?path=aplasia-cutis-congenita\" class=\"medical medical_review\">&quot;Aplasia cutis congenita&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Incontinentia pigmenti</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Incontinentia pigmenti (IP) is an X-linked dominant multisystem disease that is usually lethal in males in utero [<a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/66\" class=\"abstract_t\">66</a>]. IP is caused by mutations in the <em><span class=\"nowrap\">IKBKG/NEMO</span> </em>(inhibitor of kappa polypeptide gene enhancer in B-cells, kinase <span class=\"nowrap\">gamma/nuclear</span> factor-kappa B essential modulator) gene, encoding a regulatory protein involved in the activation of genes involved in cell survival, inflammation, and immunity. In females, it classically presents with a staged cutaneous eruption (<a href=\"image.htm?imageKey=DERM%2F109835\" class=\"graphic graphic_table graphicRef109835 \">table 5</a>); variable developmental abnormalities involving the teeth, hair, and nails; and ocular and neurologic abnormalities. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In stage 1, or the vesicular stage, erythematous papules and vesicles appear in crops in linear streaks along the lines of Blaschko, usually beginning at birth or within the first few weeks of life, with each crop lasting one to two weeks (<a href=\"image.htm?imageKey=DERM%2F78272\" class=\"graphic graphic_picture graphicRef78272 \">picture 34</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stage 2, or the verrucous stage, consists of hyperkeratotic, warty papules or plaques in linear or swirling patterns (<a href=\"image.htm?imageKey=DERM%2F53297\" class=\"graphic graphic_picture graphicRef53297 \">picture 35</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stage 3, or the pigmented stage, presents as streaks of hyperpigmentation in a &quot;marble cake pattern&quot; (<a href=\"image.htm?imageKey=DERM%2F63009\" class=\"graphic graphic_picture graphicRef63009 \">picture 36</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stage 4, or the final stage, where the hyperpigmented streaks may evolve into hypopigmented and atrophic patches or streaks.</p><p/><p>All stages may be present simultaneously and may occur in utero. The clinical features, diagnosis, and management of incontinentia pigmenti are discussed in detail elsewhere. (See <a href=\"topic.htm?path=incontinentia-pigmenti\" class=\"medical medical_review\">&quot;Incontinentia pigmenti&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Cutaneous mastocytosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cutaneous mastocytosis is an infiltrative skin disorder that can present with vesicles and blisters in the newborn (<a href=\"image.htm?imageKey=RHEUM%2F52257%7EDERM%2F115803\" class=\"graphic graphic_picture graphicRef52257 graphicRef115803 \">picture 37A-B</a>). The two main forms are cutaneous mastocytomas, presenting with solitary or multiple erythematous nodules, and maculopapular cutaneous mastocytosis (previously called urticaria pigmentosa), which presents with multiple monomorphic, reddish-brown macules and papules anywhere on the body, except the palms and soles (<a href=\"image.htm?imageKey=DERM%2F115803\" class=\"graphic graphic_picture graphicRef115803 \">picture 37B</a>). Both forms of cutaneous mastocytosis may present with bullous lesions in infants. (See <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A variety of diseases can cause vesicular or pustular eruptions on the skin of young infants. Benign and self-limited disorders, such as erythema toxicum neonatorum (<a href=\"image.htm?imageKey=DERM%2F70785\" class=\"graphic graphic_picture graphicRef70785 \">picture 1A</a>), transient neonatal pustular melanosis (<a href=\"image.htm?imageKey=PEDS%2F59397%7EDERM%2F64567\" class=\"graphic graphic_picture graphicRef59397 graphicRef64567 \">picture 2A-B</a>), and neonatal acne (<a href=\"image.htm?imageKey=DERM%2F56615\" class=\"graphic graphic_picture graphicRef56615 \">picture 3</a>), do not require specific therapy. However, certain infections and genetic disorders must be differentiated from these self-limited conditions because treatment may be needed (<a href=\"image.htm?imageKey=PEDS%2F75417\" class=\"graphic graphic_table graphicRef75417 \">table 1</a>). (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H3515631829\" class=\"local\">'Benign vesiculopustular eruptions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A thorough clinical history and physical exam provides important clues for diagnosis. The possibility of a viral, bacterial, or fungal infection should always be considered. (See <a href=\"#H2\" class=\"local\">'Infectious vesiculopustular eruptions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In addition to impetigo and localized pustulosis, <em>Staphylococcus aureus</em> infection may cause staphylococcal scalded skin syndrome (SSSS). In SSSS, toxins produced by the organism induce cutaneous erythema, bullae, and desquamation. Microscopic examination of a frozen section of lesional skin is a quick method to distinguish this disorder from toxic epidermal necrolysis. (See <a href=\"#H8\" class=\"local\">'Staphylococcal scalded skin syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Erythematous patches, papules, and pustules in intertriginous areas may occur in neonatal candidiasis (<a href=\"image.htm?imageKey=DERM%2F115797%7EPEDS%2F59361\" class=\"graphic graphic_picture graphicRef115797 graphicRef59361 \">picture 24A-B</a>). Satellite lesions are a frequent finding. (See <a href=\"#H13\" class=\"local\">'Neonatal candidiasis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Scabies in infants can present with inflammatory vesicles <span class=\"nowrap\">and/or</span> pustules (<a href=\"image.htm?imageKey=DERM%2F115804\" class=\"graphic graphic_picture graphicRef115804 \">picture 26</a>). Lesions may be widespread and often involve the hands, wrists, and feet (<a href=\"image.htm?imageKey=DERM%2F76789\" class=\"graphic graphic_picture graphicRef76789 \">picture 27</a>). (See <a href=\"#H15\" class=\"local\">'Scabies'</a> above and <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vesicular lesions following the lines of Blaschko on a newborn infant suggest the possibility of incontinentia pigmenti, a rare, X-linked dominant disorder (<a href=\"image.htm?imageKey=DERM%2F78272\" class=\"graphic graphic_picture graphicRef78272 \">picture 34</a>). Later stages of incontinentia pigmenti are characterized by verrucous papules and pigmentary alteration. (See <a href=\"#H20\" class=\"local\">'Incontinentia pigmenti'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An erosive patch or blister-like lesion on the scalp or another area of the body at birth may occur due to a local absence of skin called aplasia cutis congenita (<a href=\"image.htm?imageKey=DERM%2F89935\" class=\"graphic graphic_picture graphicRef89935 \">picture 32</a>). Aplasia cutis congenita is occasionally associated with other physical defects or genetic disorders. A conspicuous collar of hair around a lesion on the scalp may indicate the presence of an underlying neurologic defect (<a href=\"image.htm?imageKey=DERM%2F114481\" class=\"graphic graphic_picture graphicRef114481 \">picture 33</a>). (See <a href=\"#H19\" class=\"local\">'Aplasia cutis congenita'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/1\" class=\"nounderline abstract_t\">Reginatto FP, Muller FM, Peruzzo J, Cestari TF. Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study. Pediatr Dermatol 2017; 34:422.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/2\" class=\"nounderline abstract_t\">Haveri FT, Inamadar AC. A cross-sectional prospective study of cutaneous lesions in newborn. ISRN Dermatol 2014; 2014:360590.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/3\" class=\"nounderline abstract_t\">Monteagudo B, Labandeira J, Cabanillas M, et al. Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors. Pediatr Dermatol 2012; 29:166.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/4\" class=\"nounderline abstract_t\">Marchini G, Nelson A, Edner J, et al. Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant. Pediatr Res 2005; 58:613.</a></li><li class=\"breakAll\">Paller AS, Mancini AJ. Cutaneous disorders of the newborn. In: Hurwitz Clinical Pediatric Dermatology, 5th ed, Elsevier Saunders, Philadelphia 2016. p.16.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/6\" class=\"nounderline abstract_t\">Carr JA, Hodgman JE, Freedman RI, Levan NE. Relationship between toxic erythema and infant maturity. Am J Dis Child 1966; 112:129.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/7\" class=\"nounderline abstract_t\">Berg FJ, Solomon LM. Erythema neonatorum toxicum. Arch Dis Child 1987; 62:327.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/8\" class=\"nounderline abstract_t\">Ramamurthy RS, Reveri M, Esterly NB, et al. Transient neonatal pustular melanosis. J Pediatr 1976; 88:831.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/9\" class=\"nounderline abstract_t\">Barr RJ, Globerman LM, Werber FA. Transient neonatal pustular melanosis. Int J Dermatol 1979; 18:636.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/10\" class=\"nounderline abstract_t\">Hern&aacute;ndez-Mart&iacute;n &Aacute;, Nu&ntilde;o-Gonz&aacute;lez A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol 2013; 68:150.</a></li><li class=\"breakAll\">Transient benign cutaneous lesions in the newborn. In: Neonatal Dermatology, 2nd ed, Eichenfield LF, Frieden IJ, Esterly NB (Eds), Saunders, Philadelphia 2008. p.90.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/12\" class=\"nounderline abstract_t\">Niamba P, Weill FX, Sarlangue J, et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 1998; 134:995.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/13\" class=\"nounderline abstract_t\">Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002; 138:215.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/14\" class=\"nounderline abstract_t\">Ayhan M, Sancak B, Karaduman A, et al. Colonization of neonate skin by Malassezia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007; 57:1012.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/15\" class=\"nounderline abstract_t\">Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol 1999; 38:128.</a></li><li class=\"breakAll\">Paller AS, Mancini AJ. Disorders of the sebaceous and sweat glands. In: Hurwitz Clinical Pediatric Dermatology, 5th ed, Elsevier Saunders, Philadelphia 2015.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/17\" class=\"nounderline abstract_t\">Rapelanoro R, Mortureux P, Couprie B, et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132:190.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/18\" class=\"nounderline abstract_t\">Bree AF, Siegfried EC. Acne vulgaris in preadolescent children: recommendations for evaluation. Pediatr Dermatol 2014; 31:27.</a></li><li class=\"breakAll\">Hoath SB, Narendran V. The skin. In: Neonatal-Perinatal Medicine, 9th ed, Fanaroff AA,  Martin RJ, Walsh MC (Eds), Elsevier Mosby, St. Louis 2011. p.1705.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/20\" class=\"nounderline abstract_t\">Serna-Tamayo C, Janniger CK, Micali G, Schwartz RA. Neonatal and infantile acne vulgaris: an update. Cutis 2014; 94:13.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/21\" class=\"nounderline abstract_t\">Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001; 145:463.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/22\" class=\"nounderline abstract_t\">Barnes CJ, Eichenfield LF, Lee J, Cunningham BB. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol 2005; 22:166.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/23\" class=\"nounderline abstract_t\">O'Connor NR, McLaughlin MR, Ham P. Newborn skin: Part I. Common rashes. Am Fam Physician 2008; 77:47.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/24\" class=\"nounderline abstract_t\">Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131 Suppl 3:S163.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/25\" class=\"nounderline abstract_t\">Feng E, Janniger CK. Miliaria. Cutis 1995; 55:213.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/26\" class=\"nounderline abstract_t\">Humeau S, Bureau B, Litoux P, Stalder JF. Infantile acropustulosis in six immigrant children. Pediatr Dermatol 1995; 12:211.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/27\" class=\"nounderline abstract_t\">Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol 1998; 15:337.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/28\" class=\"nounderline abstract_t\">Good LM, Good TJ, High WA. Infantile acropustulosis in internationally adopted children. J Am Acad Dermatol 2011; 65:763.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/29\" class=\"nounderline abstract_t\">Jennings JL, Burrows WM. Infantile acropustulosis. J Am Acad Dermatol 1983; 9:733.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/30\" class=\"nounderline abstract_t\">Dromy R, Raz A, Metzker A. Infantile acropustulosis. Pediatr Dermatol 1991; 8:284.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/31\" class=\"nounderline abstract_t\">Van Praag MC, Van Rooij RW, Folkers E, et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol 1997; 14:131.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/32\" class=\"nounderline abstract_t\">Vignon-Pennamen MD, Wallach D. Infantile acropustulosis. A clinicopathologic study of six cases. Arch Dermatol 1986; 122:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/33\" class=\"nounderline abstract_t\">Bundino S, Zina AM, Ubertalli S. Infantile acropustulosis. Dermatologica 1982; 165:615.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/34\" class=\"nounderline abstract_t\">Kahn G, Rywlin AM. Acropustulosis of infancy. Arch Dermatol 1979; 115:831.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/35\" class=\"nounderline abstract_t\">Findlay RF, Odom RB. Infantile acropustulosis. Am J Dis Child 1983; 137:455.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/36\" class=\"nounderline abstract_t\">Narvaez-Rosales V, de-Ocariz MS, Carrasco-Daza D, et al. Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases. Int J Dermatol 2013; 52:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/37\" class=\"nounderline abstract_t\">Piersigilli F, Diociaiuti A, Boldrini R, et al. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders. Cutis 2010; 85:286.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/38\" class=\"nounderline abstract_t\">Uhara H, Shiohara M, Baba A, et al. Transient myeloproliferative disorder with vesiculopustular eruption: Early smear is useful for quick diagnosis. J Am Acad Dermatol 2009; 60:869.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/39\" class=\"nounderline abstract_t\">James SH, Kimberlin DW. Neonatal Herpes Simplex Virus Infection. Infect Dis Clin North Am 2015; 29:391.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/40\" class=\"nounderline abstract_t\">Sauerbrei A, Wutzler P. Neonatal varicella. J Perinatol 2001; 21:545.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/41\" class=\"nounderline abstract_t\">Speck WT, Driscoll JM, Polin RA, et al. Staphylococcal and streptococcal colonization of the newborn infant: effect of antiseptic cord care. Am J Dis Child 1977; 131:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/42\" class=\"nounderline abstract_t\">Mishra AK, Yadav P, Mishra A. A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. Open Microbiol J 2016; 10:150.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/43\" class=\"nounderline abstract_t\">Patel GK, Finlay AY. Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol 2003; 4:165.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/44\" class=\"nounderline abstract_t\">Ladhani S, Joannou CL, Lochrie DP, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999; 12:224.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/45\" class=\"nounderline abstract_t\">Elias PM, Fritsch P, Epstein EH. Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol 1977; 113:207.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/46\" class=\"nounderline abstract_t\">Honig PJ, Gaisin A, Buck BE. Frozen section differentiation of drug-induced and staphylococcal-induced toxic epidermal necrolysis. J Pediatr 1978; 92:504.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/47\" class=\"nounderline abstract_t\">Ito Y, Funabashi Yoh M, Toda K, et al. Staphylococcal scalded-skin syndrome in an adult due to methicillin-resistant Staphylococcus aureus. J Infect Chemother 2002; 8:256.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/48\" class=\"nounderline abstract_t\">Chi CY, Wang SM, Lin HC, Liu CC. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis 2006; 42:181.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/49\" class=\"nounderline abstract_t\">Isenberg HD, Tucci V, Lipsitz P, FAcklam RR. Clinical laboratory and epidemiological investigations of a Streptococcus pyogenes cluster epidemic in a newborn nursery. J Clin Microbiol 1984; 19:366.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/50\" class=\"nounderline abstract_t\">Campbell JR, Arango CA, Garcia-Prats JA, Baker CJ. An outbreak of M serotype 1 group A Streptococcus in a neonatal intensive care unit. J Pediatr 1996; 129:396.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/51\" class=\"nounderline abstract_t\">Kline A, O'Donnell E. Group B streptococcus as a cause of neonatal bullous skin lesions. Pediatr Infect Dis J 1993; 12:165.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/52\" class=\"nounderline abstract_t\">Barber M, Okubadejo OA. Maternal and neonatal listerosis: report of case and brief review of literature of listeriosis in man. Br Med J 1965; 2:735.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/53\" class=\"nounderline abstract_t\">Dorfman DH, Glaser JH. Congenital syphilis presenting in infants after the newborn period. N Engl J Med 1990; 323:1299.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/54\" class=\"nounderline abstract_t\">Rowen JL, Atkins JT, Levy ML, et al. Invasive fungal dermatitis in the &lt; or = 1000-gram neonate. Pediatrics 1995; 95:682.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/55\" class=\"nounderline abstract_t\">Perzigian RW, Faix RG. Primary cutaneous aspergillosis in a preterm infant. Am J Perinatol 1993; 10:269.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/56\" class=\"nounderline abstract_t\">Nanda S, Reddy BS, Ramji S, Pandhi D. Analytical study of pustular eruptions in neonates. Pediatr Dermatol 2002; 19:210.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Scabies. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/58\" class=\"nounderline abstract_t\">Quarterman MJ, Lesher JL Jr. Neonatal scabies treated with permethrin 5% cream. Pediatr Dermatol 1994; 11:264.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/59\" class=\"nounderline abstract_t\">Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126:226.</a></li><li class=\"breakAll\">Meinking T, Taplin D, Vicaria M. Infestations. In: Pediatric Dermatology, 4th ed, Schachner LA, Hansen RC (Eds), Churchill Livingstone, New York 2010. p.1584.</li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/61\" class=\"nounderline abstract_t\">Adam R, Schroten H. Picture of the month. Congenital sucking blisters. Arch Pediatr Adolesc Med 2007; 161:607.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/62\" class=\"nounderline abstract_t\">Heinecke G, Marinkovich MP, Rieger KE. Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn. Pediatr Dermatol 2017; 34:308.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/63\" class=\"nounderline abstract_t\">Radkevich-Brown O, Shwayder T. Bullous dermolysis of the newborn: four new cases and clinical review. Pediatr Dermatol 2013; 30:736.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/64\" class=\"nounderline abstract_t\">Bharti G, Groves L, David LR, et al. Aplasia cutis congenita: clinical management of a rare congenital anomaly. J Craniofac Surg 2011; 22:159.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/65\" class=\"nounderline abstract_t\">Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol 1986; 14:646.</a></li><li><a href=\"https://www.uptodate.com/contents/vesiculopustular-and-bullous-lesions-in-the-newborn-and-infant/abstract/66\" class=\"nounderline abstract_t\">Swinney CC, Han DP, Karth PA. Incontinentia Pigmenti: A Comprehensive Review and Update. Ophthalmic Surg Lasers Imaging Retina 2015; 46:650.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5790 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H23\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3515631829\" id=\"outline-link-H3515631829\">BENIGN VESICULOPUSTULAR ERUPTIONS</a><ul><li><a href=\"#H3426440751\" id=\"outline-link-H3426440751\">Erythema toxicum neonatorum</a></li><li><a href=\"#H1971323542\" id=\"outline-link-H1971323542\">Transient neonatal pustular melanosis</a></li><li><a href=\"#H480811413\" id=\"outline-link-H480811413\">Eosinophilic pustular folliculitis of infancy</a></li><li><a href=\"#H4121463882\" id=\"outline-link-H4121463882\">Neonatal cephalic pustulosis</a></li><li><a href=\"#H3098968329\" id=\"outline-link-H3098968329\">Infantile acne</a></li><li><a href=\"#H1556199306\" id=\"outline-link-H1556199306\">Miliaria</a></li><li><a href=\"#H416223681\" id=\"outline-link-H416223681\">Infantile acropustulosis</a></li><li><a href=\"#H799739628\" id=\"outline-link-H799739628\">Vesiculopustular eruption and transient myeloproliferative disorder in Down syndrome</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">INFECTIOUS VESICULOPUSTULAR ERUPTIONS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Viral infection</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- Primary herpes simplex infection</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Varicella-zoster</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">Bacterial infection</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">- Staphylococcal pustulosis</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Staphylococcal scalded skin syndrome</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Streptococcal infection</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Listeriosis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Congenital syphilis</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">Fungal infection</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">- Neonatal candidiasis</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Congenital candidiasis</a></li></ul></li><li><a href=\"#H2649463040\" id=\"outline-link-H2649463040\">Infestations</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">- Scabies</a></li></ul></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">CONGENITAL/INHERITED BULLOUS DISORDERS</a><ul><li><a href=\"#H1065231708\" id=\"outline-link-H1065231708\">Sucking blisters</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Epidermolysis bullosa</a></li><li><a href=\"#H1181776286\" id=\"outline-link-H1181776286\">Bullous dermolysis of the newborn</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Epidermolytic ichthyosis</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Aplasia cutis congenita</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Incontinentia pigmenti</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Cutaneous mastocytosis</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5790|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/113285\" class=\"graphic graphic_algorithm\">- Initial antibiotics for staph and strep SSTI in neonates</a></li></ul></li><li><div id=\"DERM/5790|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/70785\" class=\"graphic graphic_picture\">- Erythema toxicum face</a></li><li><a href=\"image.htm?imageKey=PEDS/59397\" class=\"graphic graphic_picture\">- Transient pustular melanosis</a></li><li><a href=\"image.htm?imageKey=DERM/64567\" class=\"graphic graphic_picture\">- Transient neonatal pustular melanosis 1</a></li><li><a href=\"image.htm?imageKey=DERM/56615\" class=\"graphic graphic_picture\">- Neonatal acne</a></li><li><a href=\"image.htm?imageKey=DERM/78577\" class=\"graphic graphic_picture\">- Erythema toxicum trunk</a></li><li><a href=\"image.htm?imageKey=DERM/115760\" class=\"graphic graphic_picture\">- Eosinophilic pustular folliculitis infancy scalp</a></li><li><a href=\"image.htm?imageKey=DERM/115761\" class=\"graphic graphic_picture\">- Eosinophilic pustular folliculitis infancy hand</a></li><li><a href=\"image.htm?imageKey=DERM/115785\" class=\"graphic graphic_picture\">- Neonatal acne 1</a></li><li><a href=\"image.htm?imageKey=DERM/115786\" class=\"graphic graphic_picture\">- Neonatal acne 2</a></li><li><a href=\"image.htm?imageKey=DERM/115787\" class=\"graphic graphic_picture\">- Miliaria rubra infant face</a></li><li><a href=\"image.htm?imageKey=DERM/115788\" class=\"graphic graphic_picture\">- Infantile acne 1</a></li><li><a href=\"image.htm?imageKey=DERM/115789\" class=\"graphic graphic_picture\">- Infantile acne 2</a></li><li><a href=\"image.htm?imageKey=PEDS/55627\" class=\"graphic graphic_picture\">- Miliaria crystallina</a></li><li><a href=\"image.htm?imageKey=PEDS/68376\" class=\"graphic graphic_picture\">- Miliaria rubra</a></li><li><a href=\"image.htm?imageKey=DERM/115791\" class=\"graphic graphic_picture\">- Acropustulosis of infancy 3</a></li><li><a href=\"image.htm?imageKey=DERM/77411\" class=\"graphic graphic_picture\">- Acropustulosis of infancy 1</a></li><li><a href=\"image.htm?imageKey=DERM/55499\" class=\"graphic graphic_picture\">- Acropustulosis of infancy 2</a></li><li><a href=\"image.htm?imageKey=DERM/115792\" class=\"graphic graphic_picture\">- Infantile acropustulosis 4</a></li><li><a href=\"image.htm?imageKey=PEDS/75059\" class=\"graphic graphic_picture\">- Neonatal herpes simplex virus neck vesicles</a></li><li><a href=\"image.htm?imageKey=DERM/115776\" class=\"graphic graphic_picture\">- Neonatal herpes simplex scalp</a></li><li><a href=\"image.htm?imageKey=DERM/115777\" class=\"graphic graphic_picture\">- Neonatal herpes simplex face</a></li><li><a href=\"image.htm?imageKey=DERM/115778\" class=\"graphic graphic_picture\">- Neonatal herpes simplex trunk</a></li><li><a href=\"image.htm?imageKey=DERM/58769\" class=\"graphic graphic_picture\">- Incontinentia pigmenti</a></li><li><a href=\"image.htm?imageKey=DERM/115779\" class=\"graphic graphic_picture\">- Neonatal varicella</a></li><li><a href=\"image.htm?imageKey=PEDS/107272\" class=\"graphic graphic_picture\">- Staphylococcal pustulosis</a></li><li><a href=\"image.htm?imageKey=DERM/50249\" class=\"graphic graphic_picture\">- Staphylococcal scalded skin syndrome - face</a></li><li><a href=\"image.htm?imageKey=DERM/72261\" class=\"graphic graphic_picture\">- Staphylococcal scalded skin syndrome - trunk</a></li><li><a href=\"image.htm?imageKey=DERM/115793\" class=\"graphic graphic_picture\">- Congenital syphilis bullae</a></li><li><a href=\"image.htm?imageKey=PEDS/81352\" class=\"graphic graphic_picture\">- Congenital syphilis rash on soles</a></li><li><a href=\"image.htm?imageKey=DERM/115794\" class=\"graphic graphic_picture\">- Congenital syphilis papulosquamous</a></li><li><a href=\"image.htm?imageKey=DERM/115796\" class=\"graphic graphic_picture\">- Diaper dermatitis</a></li><li><a href=\"image.htm?imageKey=DERM/115797\" class=\"graphic graphic_picture\">- Candidal diaper dermatitis 2</a></li><li><a href=\"image.htm?imageKey=PEDS/59361\" class=\"graphic graphic_picture\">- Candidal diaper dermatitis A</a></li><li><a href=\"image.htm?imageKey=PEDS/68825\" class=\"graphic graphic_picture\">- Congenital cutaneous candidiasis</a></li><li><a href=\"image.htm?imageKey=DERM/94975\" class=\"graphic graphic_picture\">- Congenital cutaneous candidiasis 2</a></li><li><a href=\"image.htm?imageKey=DERM/115804\" class=\"graphic graphic_picture\">- Scabies infant</a></li><li><a href=\"image.htm?imageKey=DERM/76789\" class=\"graphic graphic_picture\">- Scabies infant foot 1</a></li><li><a href=\"image.htm?imageKey=PEDS/78479\" class=\"graphic graphic_picture\">- Intrauterine sucking lesion</a></li><li><a href=\"image.htm?imageKey=DERM/86267\" class=\"graphic graphic_picture\">- Junctional epidermolysis bullosa Herlitz 2</a></li><li><a href=\"image.htm?imageKey=DERM/115799\" class=\"graphic graphic_picture\">- Transient bullous dermolysis</a></li><li><a href=\"image.htm?imageKey=DERM/90570\" class=\"graphic graphic_picture\">- Epidermolytic ichthyosis</a></li><li><a href=\"image.htm?imageKey=DERM/89935\" class=\"graphic graphic_picture\">- Aplasia cutis congenita scalp</a></li><li><a href=\"image.htm?imageKey=DERM/114481\" class=\"graphic graphic_picture\">- Aplasia cutis congenita membranous</a></li><li><a href=\"image.htm?imageKey=DERM/78272\" class=\"graphic graphic_picture\">- Incontinentia pigmenti 2</a></li><li><a href=\"image.htm?imageKey=DERM/53297\" class=\"graphic graphic_picture\">- Incontinentia pigmenti 3</a></li><li><a href=\"image.htm?imageKey=DERM/63009\" class=\"graphic graphic_picture\">- Incontinentia pigmenti 4</a></li><li><a href=\"image.htm?imageKey=RHEUM/52257\" class=\"graphic graphic_picture\">- Bullous eruption in skin mastocytosis</a></li><li><a href=\"image.htm?imageKey=DERM/115803\" class=\"graphic graphic_picture\">- Diffuse cutaneous mastocytosis infant</a></li></ul></li><li><div id=\"DERM/5790|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/75417\" class=\"graphic graphic_table\">- Differential diagnosis blister pustule infant</a></li><li><a href=\"image.htm?imageKey=DERM/62402\" class=\"graphic graphic_table\">- Topical corticosteroids</a></li><li><a href=\"image.htm?imageKey=PEDS/64140\" class=\"graphic graphic_table\">- Neonatal doses MRSA</a></li><li><a href=\"image.htm?imageKey=ID/66906\" class=\"graphic graphic_table\">- Neonatal GBS infection rx</a></li><li><a href=\"image.htm?imageKey=DERM/109835\" class=\"graphic graphic_table\">- Incontinentia pigmenti clinicopathologic stages</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-palmoplantar-eczema-dyshidrotic-eczema\" class=\"medical medical_review\">Acute palmoplantar eczema (dyshidrotic eczema)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aplasia-cutis-congenita\" class=\"medical medical_review\">Aplasia cutis congenita</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=benign-skin-and-scalp-lesions-in-the-newborn-and-infant\" class=\"medical medical_review\">Benign skin and scalp lesions in the newborn and infant</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-infections-in-children\" class=\"medical medical_review\">Candida infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-candida-infection-in-neonates\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Candida infection in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-listeria-monocytogenes-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Listeria monocytogenes infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-syphilis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital syphilis: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-syphilis-evaluation-management-and-prevention\" class=\"medical medical_review\">Congenital syphilis: Evaluation, management, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-management-of-glucose-6-phosphate-dehydrogenase-deficiency\" class=\"medical medical_review\">Diagnosis and management of glucose-6-phosphate dehydrogenase deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-epidermolysis-bullosa\" class=\"medical medical_review\">Diagnosis of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diaper-dermatitis\" class=\"medical medical_review\">Diaper dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=down-syndrome-clinical-features-and-diagnosis\" class=\"medical medical_review\">Down syndrome: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-classification-and-clinical-features-of-epidermolysis-bullosa\" class=\"medical medical_review\">Epidemiology, pathogenesis, classification, and clinical features of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use\" class=\"medical medical_review\">General principles of dermatologic therapy and topical corticosteroid use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=group-b-streptococcal-infection-in-neonates-and-young-infants\" class=\"medical medical_review\">Group B streptococcal infection in neonates and young infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=incontinentia-pigmenti\" class=\"medical medical_review\">Incontinentia pigmenti</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=keratinopathic-ichthyoses\" class=\"medical medical_review\">Keratinopathic ichthyoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=kindler-syndrome\" class=\"medical medical_review\">Kindler syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-in-children-treatment-of-invasive-infections\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus in children: Treatment of invasive infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=miliaria\" class=\"medical medical_review\">Miliaria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Management and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cytomegalovirus-infections-in-children\" class=\"medical medical_review\">Overview of cytomegalovirus infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-epidermolysis-bullosa\" class=\"medical medical_review\">Overview of the management of epidermolysis bullosa</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pustular psoriasis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Scabies: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=suspected-staphylococcus-aureus-and-streptococcal-skin-and-soft-tissue-infections-in-neonates-evaluation-and-management\" class=\"medical medical_review\">Suspected Staphylococcus aureus and streptococcal skin and soft tissue infections in neonates: Evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-candida-infection-in-neonates\" class=\"medical medical_review\">Treatment of Candida infection in neonates</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=varicella-zoster-infection-in-the-newborn\" class=\"medical medical_review\">Varicella-zoster infection in the newborn</a></li></ul></div></div>","javascript":null}